Management and outcome of patients with gastrointestinal cutaneous fistula in Al-Karama teaching hospital
DOI:
https://doi.org/10.18203/2349-2902.isj20185134Keywords:
Entero-cutaneous, Fistula, Gastro-intestinal, PostoperativeAbstract
Background: Gastrointestinal cutaneous fistulae are abnormal communication between stomach, small or large bowel, and the skin allowing the gastrointestinal contents to flow onto the skin. It is one of the most dreaded postoperative complications. It is a major cause of morbidity and possible mortality especially in high output fistulae. The aim of this study was to assess the pattern of postoperative gut fistulae particularly on the clinical presentation, diagnostic, work up, managements, and outcomes.
Methods: It was a prospective non-randomized study of 52 consecutive patients collected in three and half years (from 1st January 2015 to 1st June 2018) in Al-Karama Teaching Hospital. The study involved patients who had postoperative fistula in the anterior abdominal wall. Originating from the digestive tract. All the patients were subjected to history and physical examination according to a data collection sheet.
Results: There were 32 males and 20 females mean age 40.96 and the mean hospital stay (14-45) days. Author found that 42.3% of cases were due to malignancy, around 30.7% were presented following laparotomy for trauma, three cases (5.8%) is due to surgery for inflammatory bowel disease (total colectomy), and 21.2% were due to miscellaneous. Regarding site of fistula, fourteen cases had single fistulae draining from midline laparotomy incision (26.9%). ten cases (19.3%) were miscellaneous conditions. Wound dehiscence and wound infection occurred in four cases (7.7%). Multiple Organ Failure (MOF) occurred in three cases and led to death.
Conclusions: Trauma and malignancy made the major two causes of postoperative fistulae in this study. The higher output fistula, the more incidence of complications, such as sepsis, electrolyte disturbances, skin excoriation and weight loss.
References
Pickhardt PJ, Bhalla S, Balfe DM. Acquired gastrointestinal fistulas: classification, etiologies, and imaging evaluation. Radiol. 2002;224(1):9-23.
Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice:a review. Gut. 2001;49(4):iv2-10.
Williams LJ, Zolfaghari S, Boushey RP. Complications of enterocutaneous fistulas and their management. Clin Colon Rectal Surg. 2010;23(3):209-20.
Jamal AU, Hanif F, Zahid M, Ahmed M, Iqbal I. Role of early surgical diversion procedure in the management of enterocutaneous fistulae. Ann King Edward Med Uni. 2001;7(4):274-7.
Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11‐year experience of enterocutaneous fistula. Brit J Surg. 2004;91(12):1646-51.
Draus Jr JM, Huss SA, Harty NJ, Cheadle WG, Larson GM. Enterocutaneous fistula: are treatments improving?. Surg. 2006;140(4):570-8.
Misky A, Hotouras A, Ribas Y, Ramar S, Bhan C. A systematic literature review on the use of vacuum assisted closure for enterocutaneous fistula. Colorectal Dis. 2016;18(9):846-51.
Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F. Systematic management of postoperative enterocutaneous fistulas:factors related to outcomes. World J Surg. 2008;32:436-43.
Schecter WP, Hirshberg A, Chang DS, Harris HW, Napolitano LM, Wexner SD, et al. Enteric fistulas: principles of management. J Am Coll Surg. 2009;209(4):484-91.
Ugochukwu AI, Amu O, Nzegwu MA. Management and outcome of enterocutanous fistula in an urban centre in Nigeria. Advances Biores. 2011;2(1):67-72.
Cameron J. Current Surgical Therapy. 7th ed. St. Louis, MO: Mosby; 2001:156-161.
Mahkdoom Z, Komar M, Still C. Nutrition and enterocutaneous fistula. J Clin Gastroenterol. 2000;31:195-204.
Aurthi AY, Rahaman A. Average Length of Stay (ALS) of under Five Years Hospitalized Children: A Study on Bangladesh. J Heal Scien. 2017;7(5):96-100.
Taggarshe D, Bakston D, Jacobs M, McKendrick A, Mittal VK. Management of enterocutaneous fistulae: a 10-years experience. World J Gastrointes Surg. 2010;2(7):242-46.
Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J Gastrointes Surg. 2006;10(3):455-64.
Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004;240(5):825-31.
Chambers WM, Mortensen NM. Postoperative leakage and abscess formation after colorectal surgery. Best Practice Res Clin Gastroenterol. 2004;18(5):865-80.
Visschers RG, Damink SW, Winkens B, Soeters PB, Van Gemert WG. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg. 2008;32(3):445-53.
Martineau P, Shwed JA, Denis R. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?. Am J Surg. 1996;172(4):386-95.
Ghazal AH, Magdy AS, Maher ME, Mohammed TE, El-Said IA. Anterior abdominal wall fistula: a clinicopathological challenge. Alexandria Bulletin 2006;42:1-9.
Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surg. 1968;64:131-41.
Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004;240(5):825-31.
Dárdai E, Bite A. Treatment of enterocutaneous small intestine fistula using parenteral nutrition therapy. Deutsche Zeitschrift fur Verdauungs-und Stoffwechselkrankheiten. 1984;44(4):149-52.
Okoye UO, Emma-Echiegu N, Tanyi PL. Living with vesico-vaginal fistula: experiences of women awaiting repairs in Ebonyi State, Nigeria. Tan J Heal Resea. 2014;16(4).
Li‐Ling J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Brit J Surg. 2001;88(2):190-9.
